These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22302208)

  • 1. Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.
    Álvarez-Prats A; Hernández-Perera O; Díaz-Herrera P; Ucero ÁC; Anabitarte-Prieto A; Losada-Cabrera A; Ortiz A; Rodríguez-Pérez JC
    Nephrol Dial Transplant; 2012 Jul; 27(7):2720-33. PubMed ID: 22302208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of glomerulosclerosis in subtotally nephrectomized rats: effects of monotherapy with losartan, spironolactone, and their combination.
    Piecha G; Koleganova N; Gross ML; Geldyyev A; Adamczak M; Ritz E
    Am J Physiol Renal Physiol; 2008 Jul; 295(1):F137-44. PubMed ID: 18434388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway.
    Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inhibition of nuclear factor-kappaB attenuates renal injury in the 5/6 renal ablation model.
    Fujihara CK; Antunes GR; Mattar AL; Malheiros DM; Vieira JM; Zatz R
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F92-9. PubMed ID: 16896182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
    Qin J; Zhang Z; Liu J; Sun L; Hu L; Cooper ME; Cao Z
    Kidney Int; 2003 Aug; 64(2):565-71. PubMed ID: 12846751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigate the effects of compound radix notoginseng on renal interstitial fibrosis and kidney-targeting treatment].
    Xie XS; Zuo C; Zhang ZY; Liu HC; Feng SG; Zhang CL; Yuan W; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Jan; 43(1):28-33. PubMed ID: 22455126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of losartan, ramipril and their combination on left ventricular remodeling and function in spontaneous hypertensive rats].
    Xu R; Zhang Y; Zhang M; Li XC; Cai H; Chen WQ; Zhu H; Ge ZM; Zhang W
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3199-204. PubMed ID: 16405840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
    Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of rosuvastatin in experimental renal failure rats via improved endothelial function.
    Liu YZ; Liu M; Zhang YM; Kang L; Chen PZ; Wang ZF; Feng Y; Zheng JH
    Biol Res Nurs; 2013 Jul; 15(3):356-64. PubMed ID: 22544519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combining an ACE inhibitor and an angiotensin II receptor blocker on plasma and kidney tissue angiotensin II levels.
    Komine N; Khang S; Wead LM; Blantz RC; Gabbai FB
    Am J Kidney Dis; 2002 Jan; 39(1):159-64. PubMed ID: 11774115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model.
    Fujihara CK; Malheiros DM; Zatz R
    Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1810-8. PubMed ID: 17344184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory.
    Gonçalves AR; Fujihara CK; Mattar AL; Malheiros DM; Noronha Ide L; de Nucci G; Zatz R
    Am J Physiol Renal Physiol; 2004 May; 286(5):F945-54. PubMed ID: 15075190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive antifibrotic effects of pioglitazone and candesartan on experimental renal fibrosis in mice.
    Higashi K; Oda T; Kushiyama T; Hyodo T; Yamada M; Suzuki S; Sakurai Y; Miura S; Kumagai H
    Nephrology (Carlton); 2010 Apr; 15(3):327-35. PubMed ID: 20470302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
    Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
    Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA; Ganafa AA; Eatman D; Walton M; Feuerstein GZ
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II type 1 receptor-dependent nuclear factor-kappaB activation-mediated proinflammatory actions in a rat model of obstructive acute pancreatitis.
    Chan YC; Leung PS
    J Pharmacol Exp Ther; 2007 Oct; 323(1):10-8. PubMed ID: 17616560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation.
    Fanelli C; Fernandes BH; Machado FG; Okabe C; Malheiros DM; Fujihara CK; Zatz R
    Am J Physiol Renal Physiol; 2011 Sep; 301(3):F580-7. PubMed ID: 21653629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
    Zhou X; Matavelli LC; Ono H; Frohlich ED
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.